Fda Approved More Doses of Covid-19 Vaccine for Weak Immune Patients
The FDA has made it possible to give a second dose of the Pfizer/BioNTech and Moderna Covid-19 vaccines for people who have a weak immune system. These people include those who have had a solid organ transplant or are diagnosed with conditions that make them like they have no immune system at all.
The country has caught a bad virus. It is called COVID-19, and it can make people very sick. The FDA looked at data and found that when people have a third dose of certain vaccines, they are less likely to get sick.
There are three different kinds of vaccines that you can use in emergencies. There is the two dose Pfizer/BioNTech vaccine for people 12 and older, the two dose Moderna vaccine for people 18 or older, and a single shot from Johnson & Johnson for people 18 or over.
Three of these vaccines are approved by the FDA. Pfizer’s vaccine is not fully approved yet.
Some people need more than one dose of the Covid-19 vaccine. The CDC will talk about how to do this and when during their meeting on Friday.
As the committee prepares to vote on whether more doses of the vaccine should be recommended for people with weak immune systems, some groups are concerned about how this could affect a person’s ability to fight off disease.
Some believe that these vaccines can not only boost an individual’s immunity but also help them battle against common illnesses like flu and cold symptoms which often strike those who have weaker immune systems or other health conditions.
If these drugs prove effective in reducing rates of illness as well as hospital stays, then they may even provide relief financially. Because it would cost less money per patient than paying for care at hospitals during times when individuals get sicker due to being confined there by doctors’ orders while trying to recover.
Moderna said in an email, “We think that every person should have access to our vaccines.” They also said: “The need for a third dose is actually quite rare, and most people will not require it.”
An alarming study by Johns Hopkins researchers found that immunocompromised people who are vaccinated are 485 times more likely to end up in the hospital or die from Covid-19. This is undoubtedly significant and should be addressed by our fellow scientists so as not to further contribute towards this growing epidemic.
The Centers for Disease Control and Prevention estimate around nine million of us in America suffer from an immune system deficiency. Either because we’ve contracted a disease which makes our body incapable of fighting off infection, or due to the medicines we’re taking.
When Covid-19 vaccines were first released, there was hope that the vaccine would protect people who had not received them. That didn’t happen because about a third of eligible people in America have not even been vaccinated once, and so they are just as susceptible to contracting the virus from someone else.
Covid-19 is one of many new diseases popping up lately due to China, which has left some sickened by its effects on their community; but while other viruses only affect children or elderly citizens, COVID-19 affects everyone equally regardless of age group. Leaving families across our country devastated when loved ones succumb to this vicious contagious disease we’re still trying to understand more fully every day.
The FDA also recommends immunocompromised individuals maintain other precautions in order to avoid contracting the flu. Immunocompromised people should not only stay away from others who are sick, but they should wear masks and gloves as well.
For example, a person with HIV should not be in the same room as someone who might have been exposed to measles because people with compromised immune systems are more vulnerable to contracting those diseases than healthy persons.
FDA recommends that those close to immunocompromised people (such as their caregivers) should get vaccinated themselves, too. FDA’s advice is a must-listen for everyone from friends and family members of patients going through cancer treatment, someone fights HIV/AIDS or other types of medical procedures with immune compromising conditions.
The FDA now recommend immunocompromised patients check in with their doctors regularly about monoclonal antibody treatment options because this will be key to them successfully fighting off the new forms of the virus. While that can be an effective treatment for patients with weaker immune systems, the alternative is just as frightening; thousands of people have lost their lives to COVID-19 already and many more will surely lose their lives.